![Aceragen](https://i0.wp.com/www.mychesco.com/wp-content/uploads/2023/01/Aceragen.png?resize=735%2C400&ssl=1)
TERRA Phase 2 Study of ACG-701 Continues Without Modification
EXTON, PA — Aceragen, Inc. (Nasdaq: ACGN) announced the recent recommendation of its independent Data Monitoring Committee (DMC) in regard to the on-going TERRA Phase 2 study of ACG-701 in …
TERRA Phase 2 Study of ACG-701 Continues Without Modification Read More